Skip to content
Skip to navigation
SUNetID Login
SUNetID Login
Mahajan Laboratories
Department of Ophthalmology
Search form
Search
Navigation menu
About
Mission
For Patients
Contact
People
Collaborative Science Systems
Publications
Make a Gift
20 / 20 Blog Archive
Education Links
Grants and Funding
Press
Gallery
Precision Health
OMICS Lab
Overview
Proteomics
Genomics
Phenomics
ADNIV
Structure
Gene Therapy
Drug Design
Molecular Surgery
Overview
Human Molecular Surgery
Mouse Molecular Surgery
Instrumentation
Education
Databases
Lab Login
Home
Features
For Patients
Dr. Mahajan recognizes that empathy, trust, and respect are as important to patient care as his expertise in treating eye disease.
Make a Gift
The Mahajan lab is dedicated to developing urgently needed therapies for eye disease and vision restoration.
Macular Degeneration
Advanced diagnosis and treatment to save central vision.
Uveitis
Surgeries to treat and research to understand inflammation inside the eye.
Vitreoretinal Surgery
Evidence-based approaches for new surgical treatments and research to discover the molecular causes.
Diabetic Retinopathy
Fighting blindness from diabetes in adults and children.
20 / 20
Marcus Toral Defends Ph.D. Thesis
Dec 21 2020
| Posted In:
20/20 Blog
Kellie Schaefer Defends Ph.D. Thesis
Dec 18 2020
| Posted In:
20/20 Blog
Teja Chemudupati on Jeopardy!
Dec 11 2020
| Posted In:
20/20 Blog
Vu Presents Bio-X Summer Research
Oct 8 2020
| Posted In:
20/20 Blog
Disparities in Retinal Detachment Surgery for Women
Aug 19 2020
| Posted In:
20/20 Blog
Objective Measurement of Human Gene Therapy
Aug 11 2020
| Posted In:
20/20 Blog
See more news
Newswire
Iris Metastasis Regression Following Osimertinib Treatment
Retinal Cavernous Hemangioma With Multiple Saccules Not Filled With Blood
Scattered Multilayered Retinal Hemorrhage Secondary to Anterior Chamber Paracentesis, Mimicking a Hematological Disorder
Bilateral Mantle Cell Lymphoma of the Lacrimal Sac and Nasolacrimal Duct
A Woman With Bilateral Visual Field Defects
Dual Sensory Impairment and Perceived Everyday Discrimination in the United States
Bilateral Atypical Eyelid Lesions in a 50-Year-Old Woman
Moving Towards PDE6A Gene Supplementation Therapy
Pediatric Optic Neuritis—Building Foundations for a Randomized Clinical Trial
Lifetime Outcomes of Anti–Vascular Endothelial Growth Factor Treatment for Neovascular Age-Related Macular Degeneration
Clinical Phenotype and Course of PDE6A -Associated Retinitis Pigmentosa Disease
Assessment of Pediatric Optic Neuritis Visual Acuity Outcomes at 6 Months
See more